title: Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late-onset Alzheimer's disease.
abstract: In a series of sibpairs with late onset Alzheimer's disease, we have examined the segregation of the loci involved in the early onset, autosomal dominant form of the disorder by using flanking microsatellite repeat markers: thus we have used APP-PCR3 and D21S210 to examine the segregation of the amyloid-beta precursor protein (APP) gene, the markers DI 4S77 and D14S284 to examine the segregation of the presenilin 1 (PSI) gene and the markers D1S227, D1S249 and D1S419 to examine the segregation of presenilin 2 (PS2). We carried out our analyses on the whole dataset of 291 affected sibpairs, and on subsets comprising those sibpairs in which neither had an apolipoprotein E4 allele (65 affected sibpairs) and those in which both had an apolipoprotein E4 allele (165 affected sibpairs). We used the programs SPLINK to generate allele frequencies and MAPMAKER/SIBS to analyze our results. We examined the segregation of the markers D19S908 and D19S918 that are close to the apolipoprotein E (ApoE) gene as a positive control to assess whether the methods we are employing have the capability to identify known loci. The sibpair approach to the identification of genetic risk loci is relatively insensitive as indicated by the failure of the ApoE locus to reach statistical significance (P = 0.06). Nevertheless, these data suggest that neither the PS1 nor the PS2 gene is a major locus for late-onset AD, but that the APP gene cannot be ruled out as a risk locus in those sibships without an E4 allele (P = 0.014). The possibility that APP is indeed a locus for late onset disease will need confirmation in other series of familial cases.
authors.affiliation: Mayo Clinic Jacksonville, FL 32224, USA.
authors.forename: F
authors.initials: F
authors.lastname: Wavrant-De Vrièze
authors.forename: R
authors.initials: R
authors.lastname: Crook
authors.forename: P
authors.initials: P
authors.lastname: Holmans
authors.forename: P
authors.initials: P
authors.lastname: Kehoe
authors.forename: M J
authors.initials: MJ
authors.lastname: Owen
authors.forename: J
authors.initials: J
authors.lastname: Williams
authors.forename: K
authors.initials: K
authors.lastname: Roehl
authors.forename: D K
authors.initials: DK
authors.lastname: Lahiri
authors.forename: S
authors.initials: S
authors.lastname: Shears
authors.forename: J
authors.initials: J
authors.lastname: Booth
authors.forename: W
authors.initials: W
authors.lastname: Wu
authors.forename: A
authors.initials: A
authors.lastname: Goate
authors.forename: M C
authors.initials: MC
authors.lastname: Chartier-Harlin
authors.forename: J
authors.initials: J
authors.lastname: Hardy
authors.forename: J
authors.initials: J
authors.lastname: Pérez-Tur
mesh_terms: D017668:Age of Onset; D000544:Alzheimer Disease / Q000235:genetics*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D001057:Apolipoproteins E / Q000235:genetics; D005260:Female; D006801:Humans; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics; D009679:Nuclear Family
chemical_list: D016564:Amyloid beta-Protein Precursor; D001057:Apolipoproteins E